GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ectin Research AB (XSAT:ECTIN B) » Definitions » Total Stockholders Equity

Ectin Research AB (XSAT:ECTIN B) Total Stockholders Equity : kr1.90 Mil (As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Ectin Research AB Total Stockholders Equity?

Ectin Research AB's Total Stockholders Equity for the quarter that ended in Mar. 2024 was kr1.90 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Ectin Research AB's Book Value per Share for the quarter that ended in Mar. 2024 was kr0.15. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Ectin Research AB's Debt-to-Equity for the quarter that ended in Mar. 2024 was 0.40.


Ectin Research AB Total Stockholders Equity Historical Data

The historical data trend for Ectin Research AB's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ectin Research AB Total Stockholders Equity Chart

Ectin Research AB Annual Data
Trend Aug19 Aug20 Dec22 Dec23
Total Stockholders Equity
10.40 9.20 21.43 4.20

Ectin Research AB Quarterly Data
Aug19 Aug20 Mar21 Sep21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Total Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 18.82 17.48 15.32 4.20 1.90

Ectin Research AB  (XSAT:ECTIN B) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Ectin Research AB's Book Value per Share for the quarter that ended in Mar. 2024 is

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Ectin Research AB's Debt-to-Equity for the quarter that ended in Mar. 2024 is

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ectin Research AB Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Ectin Research AB's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Ectin Research AB (XSAT:ECTIN B) Business Description

Traded in Other Exchanges
N/A
Address
Pepparedsleden 1, Molndal, SWE, 431 83
Ectin Research AB is a pharmaceutical company developing a novel treatment that eliminates cancer tumors. Its drug candidate MFA-370 engages in the treatment of metastatic bladder cancer, and has also shown potential in other cancers such as breast, colorectal and prostate cancer cells.

Ectin Research AB (XSAT:ECTIN B) Headlines

No Headlines